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1 Introduction
Vitamin Ds metabolites, among other impor-
tant hormonal systems, regulate the feto-ma-
ternal calcium homeostasis during pregnancy
[11, 22]. The three main metabolites are: 25-
hydroxyvitamin Ds (25(OH)D3), which is
formed in the liver by 25-hydroxylation of vit-
amin Da, and is the precursor for further hy-
droxylation in the kidneys to 24,25-dihydroxy-
vitamin Ds (24,25(OH)2D3) and to the hormon-
ally most active form 1,25-dihydroxyvitamin Ds
(1,25(OH)2D3).
Our present knowledge of the human maternal-
fetal relationship of these metabolites is con-
fined to studies in which these metabolites were
investigated in humans by comparing post-par-
tum maternal and cord sera levels [9,10,14,15,
31]. As yet, there is not a unanimous agreement
concerning the degrees and mechanisms of
transplacental transfer from mother to fetus of
each of the three metabolites [4, 21]. Moreover,
the contribution of fetal metabolism to its own
pool of the hydroxylated metabolites is still
uncertain [11, 21]. A recent data shows that
the fetus most probably contributes to its own
1,25(OH)2D3 pool [19]. The maternal and cord
sera levels of these metabolites were not yet
correlated with another important compart-
ment — the amniotic fluid. In the past, we have
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determined amniotic fluid levels of 25(OH)D3
and 24,25(OH)2D3 during pregnancy [23]. How-
ever, the source of the amniotic fluid vitamin
D3 metabolites remained unclear.
In the present study »levels of amniotic fluid
25(OH)D3, 24,25(OH)2D3 and 1,25(OH)2D3 at
term were compared with maternal and fetal
cord serum levels. This information may be
helpful in the assessment of the source of these
metabolites in amniotic fluid.
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2 Material and methods
Amniotic fluids, fetal cord and maternal blood
samples were obtained from twenty-six normal
pregnant white women during elective cesarean
sections at 37 — 40 weeks of pregnancy during
the period of December 1982-April 1983.
None of the women received vitamin D pre-
parations during pregnancy. Fetal and ma-
ternal sera were separated by centrifugation.
The amniotic fluids obtained were not contami-
nated by blood. They were centrifuged at 3 000
r. p. m. and the cell free supernatant was frozen.
All the samples were stored at — 40 °C until
further work up.
Blood samples were extracted for lipids (1.0
volume of serum + 10 volumes of ethanol) and
the extracts (recoveries for 25(OH)D3,
24,25(OH)2D3 and 1,25(OH)2D3 were 90%,
84% and 90%, respectively) were dried under
nitrogen and redissolved in chloroform pet-
roleum ether (1 : 1 by volume). Sephadex LH-
20 (Pharmacia Fine Chemicals, Uppsala,
Sweden) column chromatography of the lipid
extracts was used to separate the vitamin D3
metabolites. The columns (0.7 χ 25 cm) were
equilibrated and developed with chloroform-
petroleum (b. p. 35-60 °C) 1 : 1 by volume [6].
The recovery of radioactivity from the columns
was always 80%-85% or more for 25(OH)D3
and 24,25(OH)2D3, and 60% or higher for
1,25(OH)2D3.
All 1,25(OH)2D3 fractions as well as several
24,25(OH)2D3 fractions obtained after Sepha-
dex LH-20 chromatography were further puri-
fied by High Pressure Liquid Chromatography
(HPLC) [17]. All Chromatographie systems
were calibrated with authentic tritiated stan-
dard metabolites (The Radiochemical Center,
Amersham, England). HPLC recoveries of
25(OH)D3, 24,25(OH)2D3 and 1,25(OH)2D3
were 88%, 60% and 75%, respectively.
Measurements of radioactivity were carried out
in a Packard Tri Carb automatic liquid scintilla-
tion spectrometer no. 3 255. Samples were dried
and counted for radioactivity in 10ml of a
solution of 0.33% 2,5-diphenyl-oxazole (PPO),
0.02% 1,4- bis (2- [4-methyl-5-phenyloxazole])
benzene (dimethyl POPOP), dissolved in a 33%
Triton X-100-toluene solvent (all Packard scin-
tillation grade, Packard Instrument C., Illinois,
USA). Quenching was accounted for by an
external standardization and correction curves
for tritium.
Established methods of competitive protein-
binding assays were used to determine
25(OH)D3, 24,25(OH)2D3 [30] and 1,25(OH)2D3
concentrations [16]. (Radioactive metabolites
purchased from The Radiochemical Center,
Amersham, England; unlabelled metabolites —
gift from F. Hoffman-La-Roche Co., Basle,
Switzerland). The receptor used in the
1,25(OH)2D3 assay was prepared in the buffer
of EISMAN, et al. [7] with the addition of sodium
molybdate [8] and kept lyophilized and refriger-
ated (-40 °C) until used.
To check for possible underestimations, con-
trols were run in which known quantities of
vitamin D3 metabolites were added to serum
samples. The assays of such controls resulted
in good quantitative recoveries (88% for
25(OH)D3; 89% for 24,25(OH)2D3). A stu-
dent's t-test was used to assess the statistical
significance of the experimental data. Where
needed, a student's t-test for unequal variance
was used. For correlating the various variants,
least squares correlation coefficients were cal-
culated.
3 Results
The results are presented in table I. The amni-
otic fluid level of 25(OH)D3 and 24,25(OH)2D3
in this study are lower than those we have
published previously and in agreement with the
findings of LASEBNIK, et al. [20] (figures 1 and
2). Our data, at that time [23] were obtained
by another assay method [13] which has since
shown to produce higher than average results
[26]. Amniotic fluid levels of 1,25(OH)2D3 are
shown in figure 3.
Fetal and maternal serum levels of the three
vitamin D3 metabolites were not statistically
different. However, the differences between ma-
ternal serum and amniotic fluid levels of the
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Figure 2. Histogram of amniotic fluid levels of 24,25
dihy dr oxycholecalcifer ol.
three metabolites were statistically significant 25(OH)D3 and 24,25(OH)2D3 (p < 0.01 for
both) but not between fetal serum and amniotic
fluid levels of 1,25(OH)2D3.
(25(OH)D3 - p < 0.01, 24,25(OH)2D3 -
p < 0.01 and 1,25(OH)2D3 - p < 0.01).
A significant differences was found between A significant correlation was found between
fetal serum and amniotic fluid levels of 25(OH)D3 levels of maternal and fetal sera
J. Perinat. Med. 15 (1987)











4.76 14.33 23.90 33.47 43.04
Annniotic Fluid 1.25(OH)D3
( pg/ ml )








Ο 12 24 36 48
Maternal 25(OH)D 3 ( n g / m l )
Figure 4. Correlation between maternal and fetal serum
levels of 25 hydroxycholecalciferol. r = 0.791 p < 0.01.
(figure 4) (r = 0.791, p < 0.01), maternal
serum and amniotic fluid (figure 5) (r = 0.697,
p < 0.01) and fetal serum and amniotic fluid
(figure 6) (r = 0.681, p < 0.01).
Maternal and fetal serum 24,25(OH)2D3 levels
were also significantly correlated (figure 7)
(r = 0.743, p < 0.01). No correlation was
found between maternal and fetal sera
1,25(OH)2D3 levels, and neither for maternal
serum and amniotic fluid, nor fetal serum and
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Figure 7. Correlation between maternal and fetal serum
levels of 24,25 dihydroxycholecalciferol. r = 0.743
p < 0.01.
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Maternal serum 1,25(OH)2D3 levels were sig-
nificantly higher (p < 0.04) at term
(36.5 + 21.5 pg/ml; n = 17) as compared with
those from normal controls (24.9 ±11.0 pg/ml;
n = 31).
4 Comment
The source of amniotic fluid vitamin D3 metab-
olites has yet to be established. Fetal urine is
the major contributor of water, ions, steroids
and other compounds to the amniotic fluid at
term [3, 18]. Another source, quantitatively of
lesser importance, is the chorionic plate of the
placenta [1]. This route was shown to exist by
the demonstration of a very rapid transfer into
amniotic fluid of relatively large lipid soluble
components such as meperidine (M. W. + 300)
which occurs, most probably through the fetal
side of the placenta from the fetal capillary
bed [28]. The amniotic fluid is also constantly
circulating through the fetal lungs which con-
tribute some of the fluid's components [5].
Data from normal adults show that urinary
concentrations of 25(OH)D3 and 1,25(OH)2D3
are low compared with their serum levels [12].
Most of these urinary vitamin D3 metabolites
are glucoronidate conjugates [12, 25]. The levels
of amniotic fluid vitamin D3 metabolites re-
ported in this study, however, were of unconju-
gated forms, similar to those in blood serum,
and were considerably higher than the levels
expected, should urinary excretion be their
main source.
The low concentrations of amniotic fluids
25(OH)D3 and 24,25(OH)2D3 and the relatively
high 1,25(OH)2D3 levels compared with cord
and maternal serum levels (table I) are consist-
ent with the data of RON, et al. [24], who studied
the in vitro transplacental transfer of these
metabolites. These authors measured maternal
to fetal transfer and demonstrated a consider-
ably higher placental clearance of 1,25(OH)2D3
compared with 25(OH)D3. The lower placental
clearance of 25(OH)D3 was proportional to its
stronger binding by the D-binding protein in
the serum added to the perfusate, and the same
may be applicable to 24,25(OH)2D3.
Our finding of a good correlation between
25(OH)D3 levels of maternal and fetal cord sera
and no correlation of 1,25(OH)2D3 levels in
these sera is consistent with some similar re-
ports [2, 14, 27] and inconsistent with others
[10, 29]. We found also a good correlation be-
tween the fetal and maternal serum levels of
24,25(OH)2D3 (r = 0.73; ρ < 0.01), which dif-
fers from the data of HILLMAN, et al. [15] and
WEISMAN et al. [30].
The mean cord serum levels of all three metab-
olites were somewhat lower than the respective
maternal serum levels. Significantly lower con-
centrations of all three metabolites were found
in the amniotic fluid as compared with the
maternal serum levels. Similar differences were
found between the concentration of 25(OH)D3
and 24,25(OH)2D3 of fetal cord serum and am-
niotic fluid. In contrast to the above, amniotic
fluid 1,25(OH)2D3 levels did not differ signifi-
cantly from those of the fetal cord serum levels
though their concentration was about half of
that of the serum. This could perhaps suggest a
higher transfer clearance of 1,25(OH)2D3 from
fetal chorionic plate capillaries into the amni-
otic fluid. However, no correlation was found
between 1,25(OH)2D3 in amniotic fluid and
fetal cord serum. There was also no correlation
between fetal serum levels of 24,25(OH)2D3 and
amniotic fluid levels of this metabolite. The
lack of correlation between the levels of these
dihydroxyvitamin D3 metabolites in fetal serum
and amniotic fluid may possibly be attributed
either to some fetal metabolism following inges-
tion of the amniotic fluid or to different sources
of these metabolites to fetal serum (i. e. from
maternal circulation, fetal production and de-
cidua [32]). Although direct transfer of these
metabolites from the decidua through the amni-
otic membrane is unlikely [1] their contribution
to the amniotic fluid by the decidua [32] cannot
be excluded. In comparison, 25(OH)D3 levels
in maternal serum and fetal serum correlated
well with their amniotic fluid levels (r = 0.697,
ρ < 0.01 andr = 0.681, ρ < 0.01 respectively).
J. Perinat. Med. 15 (1987)
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As the fetal liver is presumably incapable of
performing the 25-hydroxylation of vitamin Da
[11] the supply of this metabolite to the fetal
serum and through the chorionic plate to the
amniotic fluid is therefore most probably from
only one source e. g. — maternal serum.
In conclusion: the findings in this study are
consistant with the hypothesis that the main
source of amniotic fluid vitamin Da metabolites
is by a direct transfer from fetal serum through
the chorionic plate of the placenta, the relative
contribution of the decidua is yet to be studied.
Summary
The concentration of 25-hydroxyvitamin D3
(25(OH)D3), 24,25-dihydroxyvitamin D3
(24,25(OH)2D3) and 1,25-dihydroxy vitamin D3
(1,25(OH)2D3) were determined in amniotic fluid, fetal
cord serum and maternal serum in 26 cases of elective
cesarean sections at term. All the women had a normal
pregnancy and did not get any vitamin D fortified pre-
parations. The samples were collected during December
1982-April 1983, at 37-40 weeks of pregnancy. The
respective levels (± S. D.) of 25(OH)D3, 24,25(OH)2D3
and 1,25(OH)2D3 in maternal serum were:
18.03 ± 10.8ng/ml, 1.473 ± 1.562ng/ml and
36 ± 21.5pg/ml; in fetal cord serum: 13.15 ± 8.3 ng/
ml, 0.9 ± 0.76 ng/ml and 29.2 ± 18.55 pg/ml and in am-
niotic fluid: 0.732 ± 0.508 ng/ml, 0.121 ± 0.104 ng/ml
and 14.3 ± 10.0 pg/ml. The levels of the three metab-
olites in maternal and fetal cord serum were not statisti-
cally different. There was a statistically significant corre-
lation between maternal and fetal serum levels of
25(OH)D3 and 24,25(OH)2D3 (r = 0.79, p < 0.01 and
r = 0.743, p < 0.01 respectively). No significant correla-
tion was found in 1,25(OH)2D3 levels between maternal
and fetal cord sera. This lack of correlation may well
be in agreement with the recent findings of KOUPPALA,
et al. who demonstrated that the fetus contributes to its
own pool of 1,25(OH)2D3.
A significant difference was found between maternal
serum and amniotic fluid levels of the three metabolites.
A statistically significant difference was also found be-
tween fetal serum levels of 25(OH)D3 and 24,25(OH)2D3
and amniotic fluid levels. Fetal cord serum of
1,25(OH)2D3 were not statistically different from the
amniotic fluid levels, even though fetal cord serum levels
were higher. In in vitro studies on the transplacental
transfer of vitamin D3 metabolites, this author has
shown that placental clearance of 1,25(OH)2D3 from
maternal to fetal circulation is about ten folds higher
than that of 25(OH)D3, presumably due to the differen-
ces in binding of these two metabolites by the serum.
Our hypothesis is that transfer of vitamin D3 metabolites
into the amniotic fluid is mainly via the fetal serum
through the chorionic plate of the placenta. If this hy-
pothesis is valid, then the expected amniotic fluid levels
of the above three metabolites compared to their fetal
serum levels would be as found in this work, and in
consistance with our previous findings on the in vitro
transplacental transfer. 25-hydroxyvitamin D3 was the
only metabolite whose levels correlated significantly
both between maternal serum levels and fetal serum
levels with amniotic fluid levels (r = 0.697, p < 0.01
and r = 0.681, p < 0.01 respectively). We don't have a
good explanation for this finding except to assume that
it may give support to the supposition of GRAY, et al.
that the fetal liver does not possess the ability of 25-
hydroxylation of cholecalciferol, this maternal serum
serves as the only constant source of 25(OH)D3 enabling
a steady state to be reached between the three compart-
ments.
Keywords: Amniotic fluid, correlation, fetal cord serum, maternal serum, vitamin D3 metabolites.
Zusammenfassung
Vitamin Da-Metabolite im Fruchtwasser in Beziehung zur
Konzentration im maternalen und fetalen Serum bei
Schwangerschaften am Termin
Bei 26 primären Sectiones am Termin wurden die Kon-
zentrationen von 25-Hydroxyvitamin D3 (25(OH)D3),
24,25-Dihydroxyvitamin D3 (24,25(OH)2D3) und 1,25-
Dihydroxyvitamin D3 (1,25(OH)2D3) im Fruchtwasser,
Nabelschnurblut und maternalen Serum bestimmt. Alle
Frauen hatten einen normalen Schwangerschaftsverlauf
und keine Vitamin-D-Präparate erhalten. Die Proben
wurden in der Zeit von Dezember 1982 bis April 1983
bei Geburten zwischen der 37. und 40. Schwanger-
schaftswoche gesammelt. Die Spiegel für 25(OH)D3,
24,25(OH)2D3 und 1,25(OH)2D3 betrugen (± S. D.):
18.03 ± 10.8 ng/ml, 1.473 ± 1.562 ng/ml und
36.0 ± 21.5 pg/ml im maternalen Serum, im Nabel-
schnurblut 13.15 ± 8.3 ng/ml, 0.9 ± 0.76 ng/ml und
29.2 ± 18.55 pg/ml und im Fruchtwasser
0.732 ± 0.508 ng/ml, 0.121 ± 0.104 ng/ml und
14.3 ± 10.0 pg/ml. Bei den Konzentrationen der 3 Meta-
bolite im mütterlichen Serum und in der Nabelschnur
gab es keine statistisch signifikanten Unterschiede. Be-
züglich des 25(OH)D3 und des 24,25(OH)2D3 lag zwi-
schen maternalem und fetalem Serum eine statistisch
signifikante Korrelation vor (r = 0.79, p < 0.01 und
r = 0.743, p < 0.01). Die l,25(OH)2D3-Spiegel im ma
J. Perinat. Med. 15 (1987)
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ternalen und fetalen Serum korrelierten nicht signifikant
miteinander. Dieser Befund stimmt gut mit den neueren
Ergebnissen von KOUPPALA et al. überein, die zeigen
konnten, daß der Fet selbst zur Veränderung seines
eigenen l,25(OH)2D3-Pools beiträgt.
Bei allen 3 Metaboliten waren die Unterschiede zwischen
maternalem Serum und Fruchtwasser statistisch signifi-
kant. Beim Vergleich von Nabelschnurserum und
Fruchtwasser waren die Unterschiede bezüglich des
25(OH)D3 und 24,25(OH)2D3 statistisch signifikant,
nicht aber bezüglich des 1,25(OH)2D3; hier war eine
Tendenz zu höheren Spiegeln in der Nabelschnur zu
erkennen. Bei in vitro-Untersuchungen zum plazentaren
Transfer von Vitamin D3-Metaboliten konnte der Autor
zeigen, daß die plazentare Clearance von 1,25(OH)2D3
beim Übergang vom mütterlichen zum fetalen Kreislauf
zehnmal höher ist als die von 25(OH)D3. Wahrscheinlich
werden die beiden Metabolite im Serum unterschiedlich
gebunden. Nach unserer Hypothese erfolgt der Transfer
von Vitamin D3-Metaboliten in das Fruchtwasser haupt-
sächlich über das fetale Serum durch die Chorionplatte
der Plazenta. Die Fruchtwasserspiegel der 3 Metabolite
lägen dann im Vergleich zur Konzentration im fetalen
Serum in den Bereichen, wie wir sie auch in dieser Studie
gefunden haben. Darüber hinaus wird die Hypothese
durch unsere Ergebnisse bei den in vitro-Untersuchun-
gen zum plazentaren Transfer gestützt. Nur beim
25(OH)Ds gab es eine signifikante Korrelation sowohl
zwischen maternalem Serum und Fruchtwasser wie auch
zwischen fetalem Serum und Fruchtwasser (r = 0.697,
p < 0.01 und r = 0.681, p < 0.01). Diese Befunde sind
nicht leicht zu erklären. Möglicherweise unterstützen sie
die Auffassung von GRAY et al., die behaupten, daß die
fetale Leber nicht in der Lage ist, Cholecalciferol zu
hydroxylieren. Damit würde nur das maternale Serum
als Quelle für das 25(OH)D3 in Frage kommen und
so ein Steady-State zwischen allen 3 Kompartimenten
erreicht werden.
Schlüsselwörter: Fetales Nabelschnurserum, Fruchtwasser, Korrelation, maternales Serum, Vitamin D3-Metabolite.
Resume
Metabolites de la vitamine Da dans le liquide amniotique,
relations avec les taux seriques maternels et foetaux lors
de la grossesse ä terme
On a dose dans le liquide amniotique, le serum foetal au
cordon, et dans le serum maternel, lors de 26 cesariennes
ä terme, les concentrations de 25-hydroxyvitamine D3
(25(OH)D3), 24,25-dihydroxyvitamine D3
(24,25(OH)2D3) et de l ,25-dihydroxyvitamine D3
(1,25(OH)2D3). Toutes les femmes avaient eu une gros-
sesse normale et n'avaient pas re$u de supplementation
en vitamine D. Les echantillons ont ete preleves de
decembre 1982 a avril 1983, ä 37—40 semaines de gros-
sesse. Les taux seriques maternels respectifs (+ DS) de
25(OH)D3, de 24,25(OH)2D3 et de 1,25(OH)2D3 etaient
de: 18,03 ± 10,8 ng/ml; 1,473 ± 1,562 ng/ml et
36 ± 21,5 pg/ml; les taux respectifs au sang du cordon
de: 13,15 ± 8,3 ng/ml, 0,9 ± 0,76 ng/ml et
29.2 + 18,55 pg/ml; et les taux dans le liquide amnioti-
que de: 0,732 ± 0,508 ng/ml, 0,121 + 0,104 ng/ml et
14.3 ± 10,0 pg/ml. Les taux des trois metabolites ne
sont pas statistiquement differents chez la mere et chez
le foetus au sang du cordon. II existe une correlation
significative sur le plan statistique entre les taux mater-
nels et foetaux de 25(OH)D3 et de 24,25(OH)2D3
(r = 0,79, p < 0,01 et r = 0,743, p < 0,01, respective-
ment). II n'a pas ete trouve de correlation significative
en ce qui concerne les taux de 1,25(OH)2D3 entre la mere
et le foetus. Cette absence de correlation est bien en
accord avec les donnees recentes de KOUPPALA et col.
qui ont demontre que le foetus contribue ä son propre
pool de 1,25(OH)2D3.
On a trouve une difference significative entre les taux
des 3 metabolites au niveau du serum maternel et du
liquide amniotique. On a egalement trouve une diffe-
rence significative entre les taux seriques foetaux de
25(OH)D3 et de 24,25(OH)2D3 et les taux du liquide
amniotique. Les taux foetaux au sang du cordon de
1,25(OH)2D3 ne sont pas statistiquement differents de
ceux du liquide amniotique, meme si les taux foetaux au
sang du cordon sont plus eleves. Dans des etudes in
vitro sur le transfert trans-placentaire des metabolites
de la vitamine D3, cet auteur a montre que la clearance
placentaire de la 1,25(OH)2D3 de la circulation mater-
nelle vers la circulation foetale est environ 10 fois plus
elevee que celle de la 25(OH)D3, vraissemblablement du
fait des differences de liaison dans le serum de ces deux
metabolites. Notre hypothese est que le transfert des
metabolites de la vitamine D3 vers le liquide amniotique
s'effectue principalement par le serum foetal, ä travers le
chorion placentaire. Si cette hypothese est valide, les
taux attendus dans le liquide amniotique de ces trois
metabolites, en comparaison des taux seriques foetaux,
devraient etre ceux trouves dans ce travail, et concor-
dants avec nos donnees anterieures concernant le trans-
fert transplacentaire in vitro. La 25-hydroxyvitamine
D3 est le seul metabolite dont les taux sont correles
significativement pour les taux maternels et pour les taux
foetaux avec les taux du liquide amniotique (r = 0,697,
p < 0,01 et r = 0,681, p < 0,01 respectivement). Nous
n'avons pas de bonne explication pour ce fait sauf qu'on
peut supposer qu'il peut appuyer la supposition de GRAY
et col. que le foie foetal ne dispose pas de la capacite
de 25-hydroxylation du cholecalciferol, ainsi le serum
maternel servirait de seule source constante de
25(OH)D3 en permettant d'atteindre un equilibre stable,
entre les trois compartiments.
Mots-cles: Correlation, liquide amniotique, metabolites de la vitamine D3, serum foetal au cordon, serum maternel.
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